Peter Adamson, MD on Isatuximab-irfc for RR/MM: Is This Practice Changing?

Peter Adamson, MD of Sanofi discusses the FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma